Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 28, 2026; 32(48): 121570
Published online Dec 28, 2026. doi: 10.3748/wjg.121570
Published online Dec 28, 2026. doi: 10.3748/wjg.121570
Table 2 Demographic characteristics of pancreatic cancer patients and healthy controls included in the plasma study cohort, n (%)
| Variables | Pancreatic cancer patients (n = 28) | Healthy controls (n = 156) |
| Gender | ||
| Male | 11 (39) | 61 (40) |
| Female | 17 (61) | 95 (60) |
| Age, median (range) | 63 (33-76) | 62 (45-83) |
| Smoking history | ||
| Non-smoker | 20 (71) | 129 (83) |
| Ex-smoker | 5 (18) | |
| Smoker | 3 (11) | 27 (17) |
| Stage at diagnosis | ||
| I | 2 (7) | |
| II | 5 (18) | |
| III | 2 (7) | |
| IV | 19 (68) | |
| Lymph node invasion | ||
| Yes | 26 (93) | |
| No | 2 (7) | |
| Metastasis | ||
| Yes | 19 (68) | |
| No | 9 (32) |
- Citation: Cho WC, Yu WS, Hon TC, Cheung ETY, Wang XQ, Wong DA, Wong CSC, Cheuk W, Luk JM. Cadherin-17: A potential biomarker for early detection in pancreatic adenocarcinoma. World J Gastroenterol 2026; 32(48): 121570
- URL: https://www.wjgnet.com/1007-9327/full/v32/i48/121570.htm
- DOI: https://dx.doi.org/10.3748/wjg.121570